Cell Death Proteins, Vol 53. Vitamins and Hormones

  • ID: 1758024
  • Book
  • 198 Pages
  • Elsevier Science and Technology
1 of 4
Cell death is one of the fundamental processes by which normal development is modulated, and the importance of both necrosis and apoptosis in a number of pathologies has generated intense interest from researchers in many fields. This timely book covers both the proteins that are produced by dying cells and the proteins that signal cells to initiate cell death.
Cell Death Proteins provides an overview of the explosive interest in cellular death. Six review papers, written by researchers at the forefront of this rapidly moving field, focus on proteins that promote, signal, and inhibit cell death. Major players involved in the cell death cascade and its controls are covered, including cell cycle checkpoints, the function of interleukin-1J converting enzyme, the role of IGF-I receptor, the Bcl-2 family of proteins, viral inhibitors of apoptosis, and p53-dependent apoptosis.
Note: Product cover images may vary from those shown
2 of 4
Cell Cycle Checkpoints and Apoptosis: Potential for Improving Radiation Therapy. Structure and Function of Interleukin-1B Converting Enzyme. The Role of IGF-I Receptor in Apoptosis. BCL-2 Family of Proteins and the Hormonal Control of Cell Life and Death in Normalcy and Neoplasia. Pathways of P53-Dependent Apoptosis. Viral Inhibitors of Apoptosis. Chapter References. Subject Index.
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Litwack, Gerald.
Trained in biochemistry at the University of Wisconsin, Madison, Dr. Litwack worked on enzymology and the effects of hormones on enzyme systems. Then he was a Postdoctoral Fellow of the National Foundation for Infantile Paralysis at the Biochemical Institute of the Sorbonne in Paris. Dr. Litwack's first position was as Assistant Professor of Biochemistry at Rutgers University in 1954. Six years later, he joined the University of Pennsylvania as associate professor and four years later went to the Fels Institute for Cancer Research and Molecular Biology, as full professor, eventually becoming Deputy Director of the Institute. In 1991, he accepted the Chair of Pharmacology at Thomas Jefferson University where he is also Deputy Director of the Jefferson Cancer Institute and Associate Director for Basic Science in the Jefferson Cancer Center. Dr. Litwack's work has been in the area of mechanisms of steroid receptor action involving especially the glucocorticoid and mineralocorticoid receptors, immunophi.

Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll